Drug Enforcement Administration (DEA) creates confusion by trying to clarify cannabis
The latest example of the Drug Enforcement Administration (DEA) trying to clarify cannabis issues and legislation by creating more confusion is the notice filed in the federal register “Establishment of a New Drug Code for Marihuana Extract”. One can’t be blamed for wondering how policies, legislation and procedures on marijuana could possibly become so contrived and confusing. Is it part of a plot?
Vice News reports on the latest nonsensical notion filed by the DEA to “drill down” and get more exact information about research being conducted on CBD in particular.
A selection of our products
It is not what you think
One could easily be delighted by the fact that extracts derived from marijuana are eventually being distinguished between, but not so fast! There is always a catch. It is not as if the FDA finally gets the fact that CBD or cannabidiol doesn’t make people stoned, or that it should not be treated like THC or tetrahydrocannabinol, the compound that does make people who smoke marijuana stoned. No, CBD is still considered Schedule 1 – alongside the most dangerous substances under federal law, such as heroin, cocaine, and, for that matter, THC.
So then what is the big deal?
There is obviously no big deal. The distinction filed in the federal register is for the agency to better track which scientists are researching marijuana and which are conducting research on CBD or other extracts.
Currently, when scientists apply for approval from the DEA to study marijuana there is no way for them to specify if they intend to work on extracts. Now there will be numerical codes to separate marijuana and the derivatives of the plant. Spokesperson Russell Baer says it is an internal accounting method.
What is CBD oil good for?
CBD is about to become a formally accepted treatment for seizure in severe epilepsy and is used, often informally, for chronic pain in arthritis. It is anti-inflammatory, and it is being researched to determine its effect on tumors. Twenty-nine states have legalized it for medicinal use and state laws pertaining to CBD stay unchanged by the new FDA rule, but are also still in conflict with federal law.
All Robert J. Capecchi, Marijuana Policy Project federal policies director had to say is: “The whole policy around this plant is just so illogical” he says it is just stupid, there is no other way of describing it.
Ease restriction on CBD research
The new rule follows the introduction of legislation to senate last year to ease the restriction on CBD research. But it was stalled all this time despite the support it received.
The federal entry sparked some speculation on whether the extracts of marijuana might be scheduled separately. Baer’s final say on the matter was: “People are reading tealeaves on the matter, meantime it is straightforward and not elaborate at all.” What is CBD oil good for? Baer thinks we already have quite a good idea of that!